Guido Rasi, the new executive director of the European Medicines Agency, said the agency needs to take a fresh look at how patients gain access to the medicines that it regulates. This means further strengthening the network of European drug regulators and taking account of the role that government payers play in making it possible for patients to gain access to new drugs.
